Coloplast A/S (CBHD)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 65.08 |
|---|---|
| 52-week range | 49.48 – 84.34 |
| Return, 1 month / 3 months | +17.1% / +22.0% |
| Return, 1 year / 3 years | −15.9% / −26.0% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 30.0% |
| Worst drawdown (1 year) | -36.5% |
| Average daily value traded | 0.11M EUR |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Coloplast A/S develops and makes medical products for people with intimate healthcare needs. Its range covers ostomy care, such as stoma bags and skin barriers, continence care including catheters, and wound and skin care, along with surgical and bowel management products. Customers include hospitals, clinics and home-care users, and the company is based in Denmark, with sales across many countries.
Coloplast A/S trades under the code CBHD on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Coloplast A/S (CBHD) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 65.08 on 23 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 310 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.9% and over the last three months it rose 22.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 11.7% | ||
| From 52-week high | -21.0% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 22.0% | ||
| 6-month return | 16.9% | ||
| 12-month return, skipping the last month | -28.1% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.5% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.11M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | +17.1% |
| 3 months | +22.0% |
| 6 months | +16.9% |
| 1 year | −15.9% |
| 3 years | −26.0% |
| 5 years | −47.3% |
Signals
| 50-day / 200-day average | 58.88 / 58.26 |
|---|---|
| Golden / death cross (60 days) | Golden, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | DKK 0.6683 |
| 5 Dec 2025 | DKK 2.4057 |
| 8 May 2025 | DKK 0.6683 |
| 6 Dec 2024 | DKK 2.2721 |
| 13 May 2024 | DKK 0.6683 |
| 8 Dec 2023 | DKK 2.1384 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.